DDI Drug Name |
DDI Drug ID |
Severity |
Mechanism |
Comorbidity |
REF |
Dronedarone |
DMA8FS5
|
Minor |
Decreased metabolism of Pimecrolimus caused by Dronedarone mediated inhibition of CYP450 enzyme. |
Angina pectoris [BA40]
|
[9] |
Nifedipine |
DMSVOZT
|
Minor |
Decreased metabolism of Pimecrolimus caused by Nifedipine mediated inhibition of CYP450 enzyme. |
Angina pectoris [BA40]
|
[9] |
Voriconazole |
DMAOL2S
|
Minor |
Decreased metabolism of Pimecrolimus caused by Voriconazole mediated inhibition of CYP450 enzyme. |
Aspergillosis [1F20]
|
[9] |
Posaconazole |
DMUL5EW
|
Minor |
Decreased metabolism of Pimecrolimus caused by Posaconazole mediated inhibition of CYP450 enzyme. |
Aspergillosis [1F20]
|
[9] |
Zafirlukast |
DMHNQOG
|
Minor |
Decreased metabolism of Pimecrolimus caused by Zafirlukast mediated inhibition of CYP450 enzyme. |
Asthma [CA23]
|
[9] |
Ciprofloxacin XR |
DM2NLS9
|
Minor |
Decreased metabolism of Pimecrolimus caused by Ciprofloxacin XR mediated inhibition of CYP450 enzyme. |
Bacterial infection [1A00-1C4Z]
|
[9] |
Dalfopristin |
DM4LTKV
|
Minor |
Decreased metabolism of Pimecrolimus caused by Dalfopristin mediated inhibition of CYP450 enzyme. |
Bacterial infection [1A00-1C4Z]
|
[9] |
Clarithromycin |
DM4M1SG
|
Minor |
Decreased metabolism of Pimecrolimus caused by Clarithromycin mediated inhibition of CYP450 enzyme. |
Bacterial infection [1A00-1C4Z]
|
[9] |
Chloramphenicol |
DMFXEWT
|
Minor |
Decreased metabolism of Pimecrolimus caused by Chloramphenicol mediated inhibition of CYP450 enzyme. |
Bacterial infection [1A00-1C4Z]
|
[9] |
Troleandomycin |
DMUZNIG
|
Minor |
Decreased metabolism of Pimecrolimus caused by Troleandomycin mediated inhibition of CYP450 enzyme. |
Bacterial infection [1A00-1C4Z]
|
[9] |
Telithromycin |
DMZ4P3A
|
Minor |
Decreased metabolism of Pimecrolimus caused by Telithromycin mediated inhibition of CYP450 enzyme. |
Bacterial infection [1A00-1C4Z]
|
[9] |
Pexidartinib |
DMS2J0Z
|
Moderate |
Increased metabolism of Pimecrolimus caused by Pexidartinib mediated induction of CYP450 enzyme. |
Bone/articular cartilage neoplasm [2F7B]
|
[10] |
Lapatinib |
DM3BH1Y
|
Minor |
Decreased metabolism of Pimecrolimus caused by Lapatinib mediated inhibition of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[9] |
Tucatinib |
DMBESUA
|
Minor |
Decreased metabolism of Pimecrolimus caused by Tucatinib mediated inhibition of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[9] |
Grepafloxacin |
DMGLX0T
|
Minor |
Decreased metabolism of Pimecrolimus caused by Grepafloxacin mediated inhibition of CYP450 enzyme. |
Bronchitis [CA20]
|
[9] |
Mifepristone |
DMGZQEF
|
Minor |
Decreased metabolism of Pimecrolimus caused by Mifepristone mediated inhibition of CYP450 enzyme. |
Cushing syndrome [5A70]
|
[9] |
Ivacaftor |
DMZC1HS
|
Minor |
Decreased metabolism of Pimecrolimus caused by Ivacaftor mediated inhibition of CYP450 enzyme. |
Cystic fibrosis [CA25]
|
[9] |
MK-8228 |
DMOB58Q
|
Minor |
Decreased metabolism of Pimecrolimus caused by MK-8228 mediated inhibition of CYP450 enzyme. |
Cytomegaloviral disease [1D82]
|
[9] |
Aprepitant |
DM053KT
|
Minor |
Decreased metabolism of Pimecrolimus caused by Aprepitant mediated inhibition of CYP450 enzyme. |
Depression [6A70-6A7Z]
|
[9] |
Nefazodone |
DM4ZS8M
|
Minor |
Decreased metabolism of Pimecrolimus caused by Nefazodone mediated inhibition of CYP450 enzyme. |
Depression [6A70-6A7Z]
|
[9] |
Stiripentol |
DMMSDOY
|
Minor |
Decreased metabolism of Pimecrolimus caused by Stiripentol mediated inhibition of CYP450 enzyme. |
Epilepsy/seizure [8A61-8A6Z]
|
[9] |
Itraconazole |
DMCR1MV
|
Minor |
Decreased metabolism of Pimecrolimus caused by Itraconazole mediated inhibition of CYP450 enzyme. |
Fungal infection [1F29-1F2F]
|
[9] |
Miconazole |
DMPMYE8
|
Minor |
Decreased metabolism of Pimecrolimus caused by Miconazole mediated inhibition of CYP450 enzyme. |
Fungal infection [1F29-1F2F]
|
[9] |
Ketoconazole |
DMPZI3Q
|
Minor |
Decreased metabolism of Pimecrolimus caused by Ketoconazole mediated inhibition of CYP450 enzyme. |
Fungal infection [1F29-1F2F]
|
[9] |
Cimetidine |
DMH61ZB
|
Minor |
Decreased metabolism of Pimecrolimus caused by Cimetidine mediated inhibition of CYP450 enzyme. |
Gastro-oesophageal reflux disease [DA22]
|
[9] |
Boceprevir |
DMBSHMF
|
Minor |
Decreased metabolism of Pimecrolimus caused by Boceprevir mediated inhibition of CYP450 enzyme. |
Hepatitis virus infection [1E50-1E51]
|
[9] |
Telaprevir |
DMMRV29
|
Minor |
Decreased metabolism of Pimecrolimus caused by Telaprevir mediated inhibition of CYP450 enzyme. |
Hepatitis virus infection [1E50-1E51]
|
[9] |
Isoniazid |
DM5JVS3
|
Minor |
Decreased metabolism of Pimecrolimus caused by Isoniazid mediated inhibition of CYP450 enzyme. |
HIV-infected patients with tuberculosis [1B10-1B14]
|
[9] |
Delavirdine |
DM3NF5G
|
Minor |
Decreased metabolism of Pimecrolimus caused by Delavirdine mediated inhibition of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[9] |
Fosamprenavir |
DM4W9B3
|
Minor |
Decreased metabolism of Pimecrolimus caused by Fosamprenavir mediated inhibition of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[9] |
Cobicistat |
DM6L4H2
|
Minor |
Decreased metabolism of Pimecrolimus caused by Cobicistat mediated inhibition of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[9] |
Saquinavir |
DMG814N
|
Minor |
Decreased metabolism of Pimecrolimus caused by Saquinavir mediated inhibition of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[9] |
Amprenavir |
DMLMXE0
|
Minor |
Decreased metabolism of Pimecrolimus caused by Amprenavir mediated inhibition of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[9] |
Darunavir |
DMN3GCH
|
Minor |
Decreased metabolism of Pimecrolimus caused by Darunavir mediated inhibition of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[9] |
Atazanavir |
DMSYRBX
|
Minor |
Decreased metabolism of Pimecrolimus caused by Atazanavir mediated inhibition of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[9] |
Ritonavir |
DMU764S
|
Minor |
Decreased metabolism of Pimecrolimus caused by Ritonavir mediated inhibition of CYP450 enzyme. |
Human immunodeficiency virus disease [1C60-1C62]
|
[9] |
Verapamil |
DMA7PEW
|
Minor |
Decreased metabolism of Pimecrolimus caused by Verapamil mediated inhibition of CYP450 enzyme. |
Hypertension [BA00-BA04]
|
[9] |
Diltiazem |
DMAI7ZV
|
Minor |
Decreased metabolism of Pimecrolimus caused by Diltiazem mediated inhibition of CYP450 enzyme. |
Hypertension [BA00-BA04]
|
[9] |
Conivaptan |
DM1V329
|
Minor |
Decreased metabolism of Pimecrolimus caused by Conivaptan mediated inhibition of CYP450 enzyme. |
Hypo-osmolality/hyponatraemia [5C72]
|
[9] |
Berotralstat |
DMWA2DZ
|
Minor |
Decreased metabolism of Pimecrolimus caused by Berotralstat mediated inhibition of CYP450 enzyme. |
Innate/adaptive immunodeficiency [4A00]
|
[9] |
Crizotinib |
DM4F29C
|
Minor |
Decreased metabolism of Pimecrolimus caused by Crizotinib mediated inhibition of CYP450 enzyme. |
Lung cancer [2C25]
|
[9] |
Selpercatinib |
DMZR15V
|
Minor |
Decreased metabolism of Pimecrolimus caused by Selpercatinib mediated inhibition of CYP450 enzyme. |
Lung cancer [2C25]
|
[9] |
Idelalisib |
DM602WT
|
Minor |
Decreased metabolism of Pimecrolimus caused by Idelalisib mediated inhibition of CYP450 enzyme. |
Mature B-cell leukaemia [2A82]
|
[9] |
IPI-145 |
DMWA24P
|
Minor |
Decreased metabolism of Pimecrolimus caused by IPI-145 mediated inhibition of CYP450 enzyme. |
Mature B-cell leukaemia [2A82]
|
[9] |
Danazol |
DML8KTN
|
Minor |
Decreased metabolism of Pimecrolimus caused by Danazol mediated inhibition of CYP450 enzyme. |
Menstrual cycle bleeding disorder [GA20]
|
[9] |
Fedratinib |
DM4ZBK6
|
Minor |
Decreased metabolism of Pimecrolimus caused by Fedratinib mediated inhibition of CYP450 enzyme. |
Myeloproliferative neoplasm [2A20]
|
[9] |
Nilotinib |
DM7HXWT
|
Minor |
Decreased metabolism of Pimecrolimus caused by Nilotinib mediated inhibition of CYP450 enzyme. |
Myeloproliferative neoplasm [2A20]
|
[9] |
Imatinib |
DM7RJXL
|
Minor |
Decreased metabolism of Pimecrolimus caused by Imatinib mediated inhibition of CYP450 enzyme. |
Myeloproliferative neoplasm [2A20]
|
[9] |
Dasatinib |
DMJV2EK
|
Minor |
Decreased metabolism of Pimecrolimus caused by Dasatinib mediated inhibition of CYP450 enzyme. |
Myeloproliferative neoplasm [2A20]
|
[9] |
Netupitant |
DMEKAYI
|
Minor |
Decreased metabolism of Pimecrolimus caused by Netupitant mediated inhibition of CYP450 enzyme. |
Nausea/vomiting [MD90]
|
[9] |
Entrectinib |
DMMPTLH
|
Minor |
Decreased metabolism of Pimecrolimus caused by Entrectinib mediated inhibition of CYP450 enzyme. |
Non-small cell lung cancer [2C25]
|
[9] |
Rucaparib |
DM9PVX8
|
Minor |
Decreased metabolism of Pimecrolimus caused by Rucaparib mediated inhibition of CYP450 enzyme. |
Ovarian cancer [2C73]
|
[9] |
Abametapir |
DM2RX0I
|
Moderate |
Decreased metabolism of Pimecrolimus caused by Abametapir mediated inhibition of CYP450 enzyme. |
Pediculosis [1G00]
|
[11] |
Lonafarnib |
DMGM2Z6
|
Minor |
Decreased metabolism of Pimecrolimus caused by Lonafarnib mediated inhibition of CYP450 enzyme. |
Premature ageing appearance [LD2B]
|
[9] |
Bicalutamide |
DMZMSPF
|
Minor |
Decreased metabolism of Pimecrolimus caused by Bicalutamide mediated inhibition of CYP450 enzyme. |
Prostate cancer [2C82]
|
[9] |
Temsirolimus |
DMS104F
|
Moderate |
Increased plasma concentrations of Pimecrolimus and Temsirolimus due to competitive inhibition of the same metabolic pathway. |
Renal cell carcinoma [2C90]
|
[12] |
Voxelotor |
DMCS6M5
|
Minor |
Decreased metabolism of Pimecrolimus caused by Voxelotor mediated inhibition of CYP450 enzyme. |
Sickle-cell disorder [3A51]
|
[9] |
Larotrectinib |
DM26CQR
|
Minor |
Decreased metabolism of Pimecrolimus caused by Larotrectinib mediated inhibition of CYP450 enzyme. |
Solid tumour/cancer [2A00-2F9Z]
|
[9] |
LEE011 |
DMMX75K
|
Minor |
Decreased metabolism of Pimecrolimus caused by LEE011 mediated inhibition of CYP450 enzyme. |
Solid tumour/cancer [2A00-2F9Z]
|
[9] |
Fostamatinib |
DM6AUHV
|
Moderate |
Decreased metabolism of Pimecrolimus caused by Fostamatinib mediated inhibition of CYP450 enzyme. |
Thrombocytopenia [3B64]
|
[13] |
Brilinta |
DMBR01X
|
Minor |
Decreased metabolism of Pimecrolimus caused by Brilinta mediated inhibition of CYP450 enzyme. |
Thrombosis [DB61-GB90]
|
[9] |
Sirolimus |
DMGW1ID
|
Moderate |
Increased plasma concentrations of Pimecrolimus and Sirolimus due to competitive inhibition of the same metabolic pathway. |
Transplant rejection [NE84]
|
[12] |
Tacrolimus |
DMZ7XNQ
|
Moderate |
Increased plasma concentrations of Pimecrolimus and Tacrolimus due to competitive inhibition of the same metabolic pathway. |
Transplant rejection [NE84]
|
[12] |
----------- |
|
|
|
|
|